Teijin Moves Into Medical Implants | Chemical & Engineering News
Volume 93 Issue 9 | p. 15 | Concentrates
Issue Date: March 2, 2015

Teijin Moves Into Medical Implants

Department: Business
Keywords: implants, materials science, Japan, prostheses, trauma

Teijin will pay about $13 million for a 50% stake in the Japanese implant company Nakashima Medical. Teijin expects that its cash injection and materials science expertise will enable Nakashima Medical to grow internationally and triple its sales to $84 million by 2020. At present, the firm is focused on the Japanese market for joint prostheses and trauma implants, where its share is about 3%.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment